Companies Reporting Before The Bell
-
Cal-Maine Foods Inc (NASDAQ: CALM) is projected
to report quarterly earnings at $1.07 per share on revenue of $414.11 million.
-
Westmoreland Coal Company (NASDAQ: WLB) is
estimated to report quarterly earnings at $0.56 per share on revenue of $302.30 million.
-
Sorl Auto Parts, Inc. (NASDAQ: SORL) is projected
to report quarterly earnings at $0.47 per share on revenue of $103.59 million.
-
Cancer Genetics Inc (NASDAQ: CGIX) is expected to
report quarterly loss at $0.11 per share on revenue of $9.19 million.
-
Argos Therapeutics Inc (NASDAQ: ARGX) is
projected to report quarterly loss at $1.4 per share on revenue of $50.00 thousand.
-
Seven Stars Cloud Group Inc (NASDAQ: SSC) is
expected to report earnings for its fourth quarter.
-
STRATA Skin Sciences Inc (NASDAQ: SSKN) is
estimated to report quarterly loss at $0.9 per share on revenue of $7.35 million.
Companies Reporting After The Bell
-
Social Reality Inc (NASDAQ: SRAX) is expected to
post quarterly earnings at $0.25 per share on revenue of $14.00 million.
-
Global Eagle Entertainment Inc (NASDAQ: ENT) is
projected to post quarterly loss at $0.1 per share on revenue of $155.57 million.
-
Limbach Holdings Inc (NASDAQ: LMB) is estimated to
post quarterly earnings at $0.39 per share on revenue of $118.00 million.
-
Switch Inc (NYSE: SWCH) is projected to post
quarterly loss at $0.21 per share on revenue of $98.80 million.
-
Yogaworks Inc (NASDAQ: YOGA) is expected to post
quarterly loss at $0.21 per share on revenue of $14.59 million.
-
CDTi Advanced Materials Inc (NASDAQ: CDTI) is
projected to post quarterly loss at $0.07 per share on revenue of $5.00 million.
-
Quest Resource Holding Corp (NASDAQ: QRHC) is
estimated to post quarterly loss at $0.06 per share on revenue of $31.90 million.
-
Flexible Solutions International, Inc. (NYSE: FSI)
is projected to post quarterly earnings at $0.02 per share on revenue of $4.32 million.
-
Izea Inc (NASDAQ: IZEA) is expected to post
quarterly loss at $0.15 per share on revenue of $8.19 million.
-
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is
projected to post quarterly loss at $0.15 per share on revenue of $50.00 thousand.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.